The Claim
Oral glutamine supplementation at 30 g/day during radiochemotherapy for advanced esophageal cancer is associated with higher lymphocyte counts and enhanced lymphocyte blast formation in response to mitogens compared to no supplementation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Patients with advanced esophageal cancer receiving radiochemotherapy and taking 30 grams of oral glutamine daily have higher lymphocyte counts and stronger lymphocyte responses to mitogens than those not taking glutamine.
See the scientific wording
Oral glutamine supplementation at 30 g/day during radiochemotherapy for advanced esophageal cancer is associated with higher lymphocyte counts and enhanced lymphocyte blast formation in response to mitogens compared to no supplementation, suggesting a potential protective effect on systemic immune function during cancer treatment.
Glutamine enters the bloodstream and is used by immune cells as fuel to keep dividing and responding to signals. It also helps make a molecule that neutralizes damage from cancer treatment, so immune cells survive and work better.
What the research says
1 studyPeople with advanced esophageal cancer who took 30 grams of glutamine daily during their radiation and chemo had more immune cells and their immune cells worked better than those who didn’t take glutamine.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.